Durect Corp (NQ: DRRX)
1.310 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Apr 17, 2014  /  Add to My Watchlist      
(DRRX) Community Analysis from
April 19, 2014
(Benzinga, 11/3/10)
DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months ended September 30, 2010. Total revenues were $8.1 million for the three months ended September 30, 2010 compared to $8.4 million for the three...(read more)
Durect (DRRX) Company Overview

Durect Corporation (DRRX) focuses on the development and commercialization of pharmaceutical systems that enhance treatment capabilities associated with chronic pain, cardiovascular diseases, and central nervous system disorders. The company uses six technology platforms:

SABER: A controlled-release technology that utilizes an injectable biodegradable gel for administration of small peptides, proteins, or small molecules.

(Read more at Wikinvest )

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here